Initial Findings From the North American COVID-19 Myocardial Infarction Registry

Pharmacology, Toxicology and Pharmaceutical Science

• Heart Infarction 100%
• Coronavirinae 100%
• ST Segment Elevation Myocardial Infarction 100%
• Diseases 100%
• Infection 16%
• Prevalence 16%
• Cerebrovascular Accident 16%
• Combination Therapy 16%
• Diabetes Mellitus 16%
• Cardiogenic Shock 16%

Medicine and Dentistry

• COVID-19 100%
• Myocardial Infarction 100%
• ST Segment Elevation Myocardial Infarction 40%
• Primary Percutaneous Coronary Intervention 20%
• Angiography 13%
• Primary Outcome 13%
• Combination Therapy 6%
• Infection 6%
• Prevalence 6%
• Cardiology 6%
• Diabetes Mellitus 6%
• Apoplexy 6%
• High Risk Population 6%
• Revascularization 6%
• Cardiogenic Shock 6%